Estimating cost-effectiveness in public health: a summary of modelling and valuation methods by Kevin Marsh et al.
Marsh et al. Health Economics Review 2012, 2:17
http://www.healtheconomicsreview.com/content/2/1/17REVIEW Open AccessEstimating cost-effectiveness in public health: a
summary of modelling and valuation methods
Kevin Marsh1, Ceri J Phillips2*, Richard Fordham3, Evelina Bertranou4 and Janine Hale5Abstract
It is acknowledged that economic evaluation methods as they have been developed for Health Technology
Assessment do not capture all the costs and benefits relevant to the assessment of public health interventions. This
paper reviews methods that could be employed to measure and value the broader set of benefits generated by
public health interventions. It is proposed that two key developments are required if this vision is to be achieved.
First, there is a trend to modelling approaches that better capture the effects of public health interventions. This
trend needs to continue, and economists need to consider a broader range of modelling techniques than are
currently employed to assess public health interventions. The selection and implementation of alternative
modelling techniques should be facilitated by the production of better data on the behavioural outcomes
generated by public health interventions. Second, economists are currently exploring a number of valuation
paradigms that hold the promise of more appropriate valuation of public health interventions outcomes. These
include the capabilities approach and the subjective well-being approach, both of which offer the possibility of
broader measures of value than the approaches currently employed by health economists. These developments
should not, however, be made by economists alone. These questions, in particular what method should be used to
value public health outcomes, require social value judgements that are beyond the capacity of economists. This
choice will require consultation with policy makers, and perhaps even the general public. Such collaboration would
have the benefit of ensuring that the methods developed are useful for decision makers.
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Healthcare commissioners are faced with the challenge of
allocating resources in order to maximise their objectives
[1]. To this end they will need to use sound evidence to
inform their decisions. Despite the large investments in
the production, synthesis and dissemination of evidence
on the effectiveness and cost-effectiveness of healthcare
interventions by organisations like the National Institute
for Health and Clinical Excellence (NICE) and the Na-
tional Institute for Health Research (NIHR), the use of
evidence by healthcare decision makers remains limited
[2]. The challenges of evidence-informed decision making
are of equal, if not greater importance in the field of pub-
lic health, for which the evidence base is much less devel-
oped when compared with clinical health. A recent review* Correspondence: C.J.Phillips@swansea.ac.uk
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in any medium, provided the original work is pidentified about 150 economic evaluations in the field of
public health [3], which compares with many thousands
of economic evaluation in health more broadly [4]. If
public health interventions are to complete for scarce
resources, more evidence is required of their costs and
benefits.
The Washington Panel in the United States [5] and
the National Institute for Health and Clinical Excellence
(NICE) in the UK [6] have developed “reference cases”
that set out the range of methodologies deemed most
appropriate when undertaking an economic evaluation
of health interventions. These guidelines, however, were
developed in the context of health technology assess-
ment (HTA) and their applicability in developing prior-
ities within public health requires further consideration.
For instance, one of the challenges facing the evaluation
of public health interventions is that their objectives are
not easily captured by the standard criteria employed by
health economists, such as the Quality Adjusted Lifen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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NICE [8] has supplemented its reference case for HTA
by advocating that for public health costs should be
measured from a broader public sector perspective, and
a cost-consequence analysis (CCA) may be adopted in-
stead of cost-utility analysis (CUA).
How should economists go about capturing this broader
perspective required by public health decision makers?
Drummond et al. identified the four main challenges to
undertaking economic evaluations of public health inter-
ventions as [3]: measuring outcomes; identifying inter-
sector costs and consequences; valuing effects; and incorp-
orating equity considerations. The remainder of this paper
provides an overview of methods for overcoming two of
these challenges – measuring and valuing outcomes.
Measuring public health outcomes
This section considers two key challenges to measuring
the impact of public health interventions: attributing
short-term impact to the interventions; and the modelling
the other impacts of interventions. The effectiveness of
many public health or health promotion interventions
depends on changes in individual behaviour, thus making
outcomes difficult to attribute and generalise [9]. This
challenge has been relatively well covered in the existing
literature. For instance, Drummond et al. recommend
that, where possible, the relative effectiveness of public
health interventions should be assessed by randomised
controlled trials (RCTs) [3]. If, however, RCTs are absent
and cannot be undertaken, they recommend that gaps in
the evidence should be filled by evaluations based on nat-
ural experiments and non-experimental approaches. Fur-
ther, techniques that have been developed to analyse non-
experimental data should be more extensively used, such
as propensity scores, time series analysis of natural experi-
ments and, where appropriate, more sophisticated econo-
metric modelling and structural simulation modelling.
The second challenge, modelling the impacts not cap-
tured by effect studies, has not receive as much attention in
the public health economics literature. The types of model-
ling problem faced by the economic evaluation of public
health interventions include: estimating how behaviours
change over time, such as whether a short-term improve-
ment in diet is likely to be maintained; estimating the long-
term health impacts of behaviours, such as the impact of
sedentariness on the incidence of heart disease; estimating
the impacts of population interactions, such as sexual be-
haviour; and estimating multiple co-morbidities, such as
those associated with alcohol misuse. What techniques
should economists use to incorporate these effects into
their analyses?
There is little guidance on how to determine the best
structure of an economic model [10,11]. There is, however,
a growing literature on how the elements of a modellingproblem influence the appropriate modelling approach,
which provides an indication of how models of public
health interventions might be constructed. The literature
identifies a number of fundamental features of modelling
approaches that can be used to characterise public health
modelling problems [12-14]. First, whether the main fea-
tures of a model change over time (dynamic models) or
not (static models). The importance of this distinction for
public health modelling can be illustrated using the ex-
ample of ‘force of infection’. Public health interventions
include behavioural interventions and vaccination pro-
grammes to combat the spread of infectious diseases.
Models of infectious diseases used to estimate the impact
of such interventions may adopt a static approach, assum-
ing that the rate at which susceptible individuals become
infected is constant. Given that this rate (or force) of infec-
tion is a function of the number of interactions, level of in-
fectiousness, and the distribution of the disease in the
population, it is often more realistic to adopt a dynamic ap-
proach. This enables the rate of infection to change over
time, allowing the impact of effects such as herd immunity
to be captured by models.
Second, models can be built so that simulations take
place at a cohort or aggregate level, or to allow the behav-
iour of individuals to be tracked separately. Cohort-level
models, such as the cohort Markov models often employed
by health economists, allocate individuals to compart-
ments, and require that individuals within a compartment,
or cohort, are homogenous. Such cohort models are easier
and less resource-intensive to construct than individual-
level models, but suffer from a number of limitations. First,
the homogeneity assumption is not satisfied, for instance, if
future model states depends on individuals’ history. For in-
stance, he health impact of an individual quitting smoking
will depend on the individual’s historical consumption of
tobacco and alcohol. Second, cohort models become very
complex if they need to capture multiple co-morbidities,
such as those associated with alcohol misuse, which has
been linked with multiple health problems.
In response to these challenges with cohort-level mod-
els, a number of individual-level modelling techniques
have been proposed, including individual level Markov
models, Discrete Event Simulation, and agent-based mod-
els [15]. Of particular interest to public health economic
evaluation is agent-based models, which allows agents to
act autonomously with their own behavioural rules. Many
public health interventions are designed to influence peo-
ples’ behaviour, such as improving physical activity levels
or causing people to quit smoking. Economic evaluation
of such interventions will require an understanding of
how peoples’ behaviour responds to these interventions,
and how these behavioural impacts are maintained, or
otherwise, over time. Agent-based models have an
important role to play in such assessments.
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economic evaluation of public health interventions have
tended to be relatively simple, perhaps with the exception
of some infectious disease modelling [14]. The variety of
modelling approaches available can provide a more accur-
ate assessment of the efficiency of public health interven-
tions. The value of more complex modelling approaches
has recently been acknowledged by NICE, which has
started to request more complex modelling approaches. If
these approaches are to be successful, however, it is import-
ant that the evidence base available to economists is
improved. The conclusion section consider the type of evi-
dence that would support this research agenda.
Valuing public health outcomes
If economists are to value the broader range of outcomes
generated by public health interventions, a new valuation
approach will be required. What approach should be
adopted? One alternative to capturing multiple, non-health
outcomes is to undertake a cost-consequence analysis
(CCA). The CCA provides a ‘balance sheet’ of outcomes
that policy makers can weigh up against the costs of an
intervention. This option is advocated by NICE in its pub-
lic health methods guidelines [8]. The draw back to a CCA
is, however, that it provides no guidance as to how the dif-
ferent outcomes included in the ‘balance sheet’ should be
weighed against each other. This is problematic, for in-
stance, when some outcomes show benefits and others
show dis-benefits, and it becomes necessary to ask about
the relative value of these outcomes.
The remainder of this section describes the following
alternatives approaches to valuing the outcomes gener-
ated by public health interventions identified in the lit-
erature: cost-benefit analysis (CBA) based on preferential
valuation techniques; alternative non-preference-based
approaches, the capability and subjective well-being
(SWB) approaches; and multi-criteria decision analysis
(MCDA).
Cost benefit analysis
The limitations with the CUA and CCA can be over-
come by valuing outcomes monetarily and undertaking a
CBA. This is a method commonly employed in environ-
mental economics [16], where a range of approaches
have been applied to value policy outcomes, including:
travel cost method; hedonic price method; and the con-
tingent valuation (CV) approach [16-18]), with the latter
becoming increasingly popular in the economic evalu-
ation of healthcare programmes [19]. The reliability of
stated preference approaches have been debated at
length in the environmental economics literature. The
National Oceanic and Atmospheric Administration
(NOAA) convened an eminent panel to assess the CV
methodology – a form of stated preference. The panelconcluded that this is a valid approach, provided it is
done properly [20].
CBA is recommended by the HM Treasury’s Green
Book [21] due to its ability to “to take account of the
wider social costs and benefits” and provide outcome
measures that are directly comparable with intervention
costs. CBA is, however, an approach that is relatively
rare in the assessment of public health interventions.
Drummond et al’s review of economic evaluations of
public health identified no CBAs [3]. McDaid and Nee-
dle found that only 5% of the public health economic
evaluations used CBA [22].
A key challenge to conducting a CBA is generating
monetary values of policy outcomes. In the absence of
market prices for outcomes, which is often the case
when evaluating public policy, the Green Book recom-
mends that either revealed preference or stated prefer-
ence methods are used to value outcomes. Revealed
preference approaches value outcomes using the prefer-
ence information revealed through existing markets. For
example, the value of preventing a fatality (VPF) has
been calculated by estimating the compensating differen-
tials for on-the-job risk exposure in labour markets, or
the amount that people are willing to pay for products
that reduce risks, such as for automobiles and fire
alarms [23]. However, the validity of the estimates pro-
duced by revealed preference techniques depend on the
ability to isolate, for instance, the impact of VPF from
the other factors that determine wages and prices. Fur-
thermore, the revealed preference approach is based on
the assumption that markets work well. The difficulty in
fulfilling these requirements is thought to explain the
large variation in estimates produced by revealed prefer-
ence studies, with, for example, VPF estimates ranging
from £0.5 million to £64.0 million [24].
Given the difficulties posed by the revealed preference
approach, economists have turned to stated preference
approaches to value non-market goods. Stated prefer-
ence studies construct a hypothetical contingent market
where the individual is surveyed to identify their willing-
ness to pay (WTP) for the non-market good. Since the
1990s, the stated preference literature has grown rapidly,
especially within environmental economics. Stated pre-
ference techniques have been used to identify the rela-
tive value of public health outcomes. For instance, a
discrete choice experiment (DCE) was undertaken re-
cently to determine the relative values health decision
makers in the UK place on the cost-effectiveness, impact
on health inequalities, and population reached by public
health interventions [25]. The advantage of stated prefer-
ence approaches is their ability to directly elicit the in-
formation that is required. However, stated preference
techniques face a number of challenges, with probably
the main one being the assumption that individuals have
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have been identified as evidence that such coherent pre-
ference may not be observed in practice [24].
Alternative notions of well-being
Despite reassurances from organisations like the NOAA,
concerns about the challenge facing preference-based
approaches described above have caused economists to
search for alternative, non-preference-based notions of
value. Two alternatives that have recently received most at-
tention are the capability approach and the SWB approach.
Developed by Amartya Sen, the capability approach
advocates that programmes are evaluated based on their
impact on the extent to which a person is able (has the
capability) to function in a particular way [26]. An ex-
ample of the capability approach being applied in health
economics is Birmingham University’s development of a
measure of capability wellbeing for adults [27]. This iden-
tifies five over-arching attributes of capability wellbeing:
stability, attachment, achievement, autonomy and enjoy-
ment. Each attribute is then described using four response
categories. In its use of a descriptive system based on
dimensions or attributes, the evaluation approach pro-
posed by the capability approach is similar to the QALY
approach. The key difference between these evaluation
approaches is that the descriptive system employed by the
QALY is limited to one dimension – health – and to func-
tioning rather than capability – health status rather than
the capability (freedom) to pursue health improvement
[26]. Furthermore, the capability approach does advocate
a preference-based approach to weight attributes.
The capability approach has been criticised for relying
on expert opinion about what contributes to well-being,
and an inability to generate a monetary estimate of benefit
[28]. Another alternative has been suggested that does not
suffer from these limitations – SWB. The SWB approach
involves measuring how people’s self-assessment of their
well-being varies as they experience outcomes targeted by
policy. Well-being assessments are elicited, for instance, in
responses to questions such as how satisfied people are
with their life overall. Answers are generally recorded on
scales ranging from, for instance, 1 for not satisfied at all to
7 for completely satisfied.
The SWB approach to valuing non-market goods is in-
creasingly being employed by economists as an input to
public policy making [23]. Furthermore, the possibilities
of SWB measures are also being recognised by policy
makers themselves. Perhaps most prominent among
these initiatives was President Nicolas Sarkozy’s commis-
sion into measuring progress, which was chaired by a
number of eminent Nobel Prize-winning economists
[29], and David Cameron’s request that the Office of Na-
tional Statistics measure the happiness of population in
the UK [30].There was initial scepticism about whether responses
to life satisfaction questions could be sensitive enough to
capture the effect of policy outcomes. There is, however,
a growing literature on the sensitivity and validity of
responses to life satisfaction questions. Responses yield
consistent and intuitively appealing associations between
well-being and life experiences, such as health and em-
ployment [23,31]. Responses have been shown to have a
causal relationships with actual behaviour, e.g. suicide,
and key physiological variables [28]. Psychological stud-
ies showing how those with higher scores are more likely
to be rated as happy by friends and less likely to show
signs of mental disorder [31].
Thus, the SWB approach is attracting attention as a
possible solution to the challenges associated with
preference-based measures of value, and could provide a
more holistic approach to capturing and valuing the out-
comes associated with public health interventions. It is
important, however, to note that the approach is still in
its infancy and that a number of methodological ques-
tions need to be answered before this approach can be
used to generate evidence to inform policy making [32].
Multi-criteria decision analysis
Multi-criteria decision analysis (MCDA) approaches vary
according to the source and nature of information used to
inform decision making, but they include four common
steps: identifying interventions; identifying evaluation cri-
teria; measuring the interventions against the criteria; and
combining the criteria scores using a weighting to produce
an overall assessment of each intervention. MCDA
approaches have been adopted across a range of policy
areas, including by environmental economists [33]. A key
feature of MCDA – its ability to capture a range of policy
outcomes – is the reason that there has been a recent in-
crease in attention in the approach from amongst health
economists interested in capturing a broader value in a
more systematic manner [34].
There are already a number of examples of MCDA
having been successfully applied to the prioritisation of
public health interventions. For instance, the US by
the Preventive Services Task Force ranked a list of
clinical preventative interventions based on their cost-
effectiveness and clinical preventable burden [35,36].
More recently a MCDA approach has been used to
prioritise preventative health interventions in England
[25,37,38].
MCDA approaches vary according to the source and
nature of information used. The range of approaches
adopted is referred to as ‘the socio-technical system’, or
the balance between decision maker input and re-
searcher measurement. The different components of the
MCDA can each be classified as either deliberative or
data-driven, depending on the source of data drawn on.
Marsh et al. Health Economics Review 2012, 2:17 Page 5 of 6
http://www.healtheconomicsreview.com/content/2/1/17Data-driven approaches to weighting/valuing policy out-
comes could, for instance, include the preferential and ex-
periential approaches referred to above. Deliberation
refers to the process of negotiation between various stake-
holders, usually through the use of workshops. There is
disagreement as to exactly what balance should be struck
between decision maker and researcher input into a
MCDA, with the answer to this question being a function
of the objective of the MCDA [39]. It is, however, import-
ant to acknowledge two key benefits of more deliberative
approaches to weighting policy outcomes. First, they are
often less time- and resource-intensive. Thus, they can be
replicated in different localities, generating locally specific
outcome valuations. Second, they engage decision makers
in the evaluation process, ensuring their buy-in to the
results of the evaluation. This helps address a key chal-
lenge of more traditional HTA – the utilisation of eco-
nomic evaluation evidence by decision-makers [2].
Conclusion
The evaluation of the efficiency of public health inter-
ventions, both relative to each other and to other health
and social care interventions, is necessary if the max-
imum benefits are to be derived from the use of public
resources. This paper considers the methods required to
better measure and value the outcomes generated by
public health interventions. We propose two areas of
method development as being priority.
First, more work is required to determine the appropri-
ate methods for, and to provide data to support, the mod-
elling of behavioural outcomes and the link between these
outcomes and health and other outcomes. We welcome
the move to more complex modelling approaches of be-
haviour in the economic analysis of public health inter-
ventions. These approaches offer the potential to provide
a more accurate assessment of the efficiency of public
health interventions. Two research initiatives would facili-
tate the development of these models. Further work is
required to determine the most appropriate types of
model for different behavioural outcomes. Health econo-
mists often adopt Markov models to simulate intervention
effects. It is, however, recognised within HTA that Markov
models are not always the most appropriate way to model
health outcomes. Alternatives, such as Discrete Event
Simulation, are proposed as more appropriate in certain
circumstances. It is important that economists working in
public health consider the relative merits of these alterna-
tive modelling approaches, rather than simply adopting
the conventions that have, at least so far, served HTA well.
The selection and implementation of appropriate mod-
elling approaches will be supported by the development
of a better empirical understanding of behavioural dy-
namics and the relationship of behaviour and health. For
instance, existing panel survey data should be analysed todetermine the dynamics of relevant public health beha-
viours, such as physical activity, diet, smoking, alcohol
consumption, and sexual behaviour. This evidence
should also be analysed to determine the impact of these
behaviours on health outcomes, by age and accumulated
behaviour.
Second, further research should be undertaken into how
to value public health outcomes. The wide range of out-
comes generated by public health interventions cannot be
captured by the valuation techniques conventionally used
in HTA. One response to this challenge would be to adopt
the approaches of economist working in other policy
areas, such as the environment, and use revealed and sta-
ted preference approaches to value outcomes monetarily
and undertake a CBA. These approaches, however, face a
number of methodological challenges. Beyond these
methods considerations, it is also important to ask
whether the nature of the valuations implicit in these
approaches is desirable. First, both stated and revealed
preference approaches base valuation on population pre-
ferences. Economists have been exploring the possibility
of alternative approaches based on population experiences
or capabilities. Second, valuation approaches need to be
transparent and acceptable to the decision makers using
the outcome of economic evaluations. Given these alter-
natives, we agree with Drummond et al. [3] that there
should be more debate about the value propositions
underlying the various forms of economic evaluation, and
their appropriateness for assessing public health interven-
tions. Furthermore, this debate needs to involve the deci-
sion makers using the outputs from economic research.
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